Grant: Canada Research Chairs
University of Toronto
$50,000.00
Nanobioengineering
FY 2024-25
Summary
Dr. Chan and his team aim to engineer nanotechnologies to carry drugs and contrast agents to tumours, which can improve the treatment and diagnosis of cancer. However, getting enough of these nanoparticles into the tumours is a significant challenge. Researchers must find the best size, shape, surface chemistry, or other physico-chemical properties of the nanoparticles that can effectively transport them into the tumour. There is a need to map the relationship between nanoparticles’ design and the interacting tissues, cells, and molecules in the body to help engineers build nanoparticles to target the tumour and avoid the healthy bodily organs.
Thus, Dr. Chan’s research program aims to elucidate and map the nanoparticle transport mechanism in the body to guide the engineering of nanoparticles for targeting and treating tumours. In the last seven years, his team has mapped the nanoparticle distribution in the body at the cell and tissue levels. The proposed project aims to map the nanoparticle transport at the molecular level, which determines the specific cells and tissues the nanoparticles interact with during their transport journey from the injection site to the tumour. The team combines cutting-edge genome screening, mass spectrometry, and STRING analysis to map nanoparticle interactions with specific cell receptors. They will vary the nanoparticle design to determine its impact on molecular interactions and transport kinetics. Finally, they will test three different strategies to alter the nanoparticle transport using the data from these fundamental studies. The results will be organized into a database that can be mined to determine the best nanoparticle design for targeting diseased tissues in the body.
This project is novel, as the molecular interactions governing nanoparticle transport in the body remain unknown. The reason is due to limited methods for such an investigation. Dr. Chan and his group developed these techniques in the last five years, uniquely positioning him for this research project. The significance of the work will be the development of nano-bio interaction data and a database that will guide engineers in constructing nanoparticles to carry cancer agents to treat and detect the disease effectively. Delivery of medical agents is one of the significant challenges in the 21st century, and the advances from the CRC award will move us closer to solving the delivery problems.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
CRC-2023-00144
Name nom
Chan, Warren
Department département
Biomedical Engineering - University of Toronto
Organization id
31
Institution établissement
University of Toronto
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2024
Competition year année de concours
2023
Award amount
50000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
9999
Research subject group en
Not available
Research subject group fr
Non disponible
Research subject en
Not available
Research subject fr
Non disponible
Field of research list codes
RDF2110103
Field of research list names en
Nanoelectromechanical systems
Field of research list names fr
Systèmes nanoélectromécaniques
Socioeconomic objective list codes
RDS10701
Socioeconomic objective list names en
Human health procedures and pharmaceutical treatments
Socioeconomic objective list names fr
Interventions et traitements pharmaceutiques ayant trait à la santé humaine
Application title
Nanobioengineering
Keywords
Nanotechnology; Diagnostics; Transport and Delivery; Targeting; Protein Corona; Bioengineering
Application summary
Dr. Chan and his team aim to engineer nanotechnologies to carry drugs and contrast agents to tumours, which can improve the treatment and diagnosis of cancer. However, getting enough of these nanoparticles into the tumours is a significant challenge. Researchers must find the best size, shape, surface chemistry, or other physico-chemical properties of the nanoparticles that can effectively transport them into the tumour. There is a need to map the relationship between nanoparticles’ design and the interacting tissues, cells, and molecules in the body to help engineers build nanoparticles to target the tumour and avoid the healthy bodily organs.
Thus, Dr. Chan’s research program aims to elucidate and map the nanoparticle transport mechanism in the body to guide the engineering of nanoparticles for targeting and treating tumours. In the last seven years, his team has mapped the nanoparticle distribution in the body at the cell and tissue levels. The proposed project aims to map the nanoparticle transport at the molecular level, which determines the specific cells and tissues the nanoparticles interact with during their transport journey from the injection site to the tumour. The team combines cutting-edge genome screening, mass spectrometry, and STRING analysis to map nanoparticle interactions with specific cell receptors. They will vary the nanoparticle design to determine its impact on molecular interactions and transport kinetics. Finally, they will test three different strategies to alter the nanoparticle transport using the data from these fundamental studies. The results will be organized into a database that can be mined to determine the best nanoparticle design for targeting diseased tissues in the body.
This project is novel, as the molecular interactions governing nanoparticle transport in the body remain unknown. The reason is due to limited methods for such an investigation. Dr. Chan and his group developed these techniques in the last five years, uniquely positioning him for this research project. The significance of the work will be the development of nano-bio interaction data and a database that will guide engineers in constructing nanoparticles to carry cancer agents to treat and detect the disease effectively. Delivery of medical agents is one of the significant challenges in the 21st century, and the advances from the CRC award will move us closer to solving the delivery problems.